No abstract available
MeSH terms
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Agents, Phytogenic / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / analysis
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Clinical Trials, Phase III as Topic
-
Docetaxel
-
Drug Administration Schedule
-
Female
-
Humans
-
Infusions, Intravenous
-
Meta-Analysis as Topic
-
Neoplasm Staging
-
Paclitaxel / administration & dosage
-
Paclitaxel / therapeutic use*
-
Predictive Value of Tests
-
Prognosis
-
Receptor, ErbB-2 / analysis
-
Retrospective Studies
-
Taxoids / therapeutic use
Substances
-
Antineoplastic Agents, Phytogenic
-
Biomarkers, Tumor
-
Taxoids
-
Docetaxel
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Paclitaxel